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Abstract: 
Kwashiorkor, an enigmatic form of severe acute malnutrition (SAM), is the 
consequence of inadequate nutrient intake plus additional environmental insults. To 
investigate the role of the gut microbiome, we studied 317 Malawian twin pairs during 
the first 3 years of life; 50% of twin pairs remained well-nourished, while 43% became 
discordant and 7% manifested concordance for acute malnutrition. Discordance was not 
affected by zygosity or gender. Both co-twins discordant pairs with kwashiorkor were 
treated with a peanut-based, ready-to-use therapeutic food (RUTF). Time-series 
metagenomic studies of 9 same-gender pairs who remained well-nourished and 13 who 
became discordant for kwashiorkor revealed that RUTF produced a transient maturation 
in the representation of metabolic functions in kwashiorkor microbiomes that regressed 
shortly after cessation of RUTF. Previously frozen fecal communities from several 
discordant pairs were each transplanted into gnotobiotic mice given a representative, 
nutrient-deficient Malawian diet followed by RUTF and then the Malawian diet. 
Metagenomic, mass spectrometric and NMR studies revealed that the combination of a 
Malawian diet and a kwashiorkor microbiome produced marked weight loss in the 
gnotobiotic mice, accompanied by perturbations in amino acid, carbohydrate and 
intermediary metabolism that were only transiently ameliorated with RUTF. These 
findings implicate the gut microbiome as a causal factor in kwashiorkor and suggest that 
additional nutritional support may be required to correct persistent metabolic defects 
arising from microbiome dysfunction in malnourished children.  
One Sentence Summary:  
Time series studies of 317 Malawian twins pairs aged 0-3 years, including those 
discordant for kwashiorkor, plus analyses of the effects of transplanting gut 
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microbiomes from twins discordant for kwashiorkor into gnotobiotic mice fed a 
nutrient-deficient Malawian diet or a ready-to-use therapeutic food, reveal the 
importance of environmental factors, notably the gut microbial community and diet, in 
development of this form of severe acute malnutrition.  
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Main Text: 
Malnutrition is the leading cause of child mortality worldwide (1).  Moderate 
acute malnutrition (MAM) refers to simple wasting with a weight-for-height Z score 
(WHZ) less than two but greater than three standard deviations below the median 
defined by World Health Organization (WHO) Child Growth Standards (2). Severe 
acute malnutrition (SAM) refers to either marasmus, which is extreme wasting with 
WHZ scores less than -3, or kwashiorkor.  Kwashiorkor is a virulent form of SAM 
characterized by generalized edema, hepatic steatosis, skin rashes and ulcerations, and 
anorexia (3,4).  The cause of kwashiorkor remains obscure. Speculation regarding its 
pathogenesis has focused on inadequate protein intake and/or excessive oxidative 
stress, but substantial evidence to refute these hypotheses has come from epidemiologic 
surveys and clinical trials (5-8). We recently conducted a comparative metagenomic 
study of the gut microbiomes of 531 healthy infants, children and adults, representing 
151 families, living in the USA, Venezuela, and Malawi; it revealed a maturational 
program where the proportional representation of genes encoding functions related to 
micro- and macronutrient biosynthesis and metabolism changes as healthy infants and 
children develop (9). Together, these observations give rise to the following testable 
hypotheses: (i) the gut microbiome provides essential functions needed for healthy 
postnatal growth and development; (ii) disturbances in microbiome assembly and 
function (e.g., those prompted by enteropathogen infection), affect the risk for 
kwashiorkor; and (iii) in a self-reinforcing pathogenic cascade, malnutrition affects gut 
microbiome functions involved in determining nutritional status, thus further 
worsening health status. A challenge is that there may be a number of gut microbiome 
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configurations associated with kwashiorkor among different hosts and even within a 
given host over time. Moreover, microbiome configurations associated with 
kwashiorkor may be differentially affected by therapeutic food interventions and 
features that are reconfigured during treatment may not persist after its withdrawal.  
To begin to address some of these hypotheses, and challenges we performed a 
longitudinal comparative metagenomic study of the fecal microbiomes of monozygotic 
(MZ) and dizygotic (DZ) twin pairs born in Malawi who became discordant for SAM. 
Malawi has one of the highest infant mortality rates in the world (1), with 35% of 
childhood deaths associated with malnutrition (10). We reasoned that a healthy (well-
nourished) co-twin in a twin pair discordant for kwashiorkor represented a very 
desirable control given his/her genetic relatedness to the affected co-twin, and their 
similar exposures to diet, the microbiota of family members and other microbial 
reservoirs in their shared early environment. A RUTF composed of peanut paste, sugar, 
vegetable oil and milk fortified with vitamins and minerals has become the international 
standard of treatment for SAM (11). In Malawi, the standard of care for twins discordant 
for kwashiorkor is to treat both co-twins with RUTF to limit food sharing; this practice 
allowed us to compare and contrast their microbiomes prior to, during and after 
treatment. Following each child in a twin pair prospectively permitted each individual 
to serve as his or her own control. Moreover, if there are many different routes to 
disrupted microbiome structure/function, then each discordant twin pair could provide 
a ‘vignette’ of underlying pathology. Finally, as an additional set of controls, we defined 
temporal variation of the fecal microbiomes in twin pairs who remained well-nourished, 
lived in the same geographic locations as discordant pairs, and never received RUTF.  
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A total of 317 twin pairs less than 3 years old were enrolled, regardless of their 
health status, from five villages (Makhwira, Mitondo, M’biza, Chamba, Mayaka) in the 
southern region of Malawi. The average age at enrollment was 9±6 months (mean ± SD). 
All but 19 twin pairs were breastfeeding at the time of enrollment (age at cessation of 
breastfeeding, 18±5 months). Children were followed until they were 36 months old. 
Zygosity testing (see Methods) revealed that 46 (15%) of twin pairs were monozygotic. 
The percentage of same-gender twin pairs in the cohort was significantly higher than 
opposite gender pairs [p<10-8, Binomial test, probability of success = 0.66, Confidence 
Interval = (0.61, 0.71), table S1A]. We did not have information about the order in which 
each child in a twin pair was born. 
Nutritional status was assessed monthly. Every attempt was made to collect a 
fecal sample every 8 weeks until 1 year of age, and every 12 weeks thereafter. Fecal 
samples were frozen in cryogenic storage containers at -190oC within 10 min after they 
were produced, and stored at -80oC. Kwashiorkor was diagnosed based on the presence 
of bilateral pitting pedal edema (12). Marasmus was diagnosed when an infant or child 
had a WHZ less than -3. Children with WHZ scores between -2 and -3 were classified as 
MAM (2). Among 244 mothers tested for HIV, 14 were positive; of the 147 children 
surveyed, only 1 was positive.  
Twin pairs who developed kwashiorkor or marasmus immediately received 
RUTF; those with MAM were given a soy-peanut ready-to-use supplementary food (13). 
After diagnosis with SAM, anthropometry was assessed and a fecal sample was 
collected every two weeks until the child recovered (defined as WHZ score greater than 
-2 and no edema).  
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Fifty percent of twin pairs remained well-nourished throughout the study while 
43% became discordant and 7% manifested concordance for acute malnutrition (table 
S1A). The prevalence of discordant compared to concordant phenotypes was significant 
(p<10-15, Binomial and Chi-squared tests). MAM was significantly more frequent than 
SAM, affecting 81 ( 60%) of the 135 discordant twin pairs (p=0.02, Chi-square test). Of 
the 634 children in the study, 7.4% developed kwashiorkor, 2.5% marasmus, and 13.9% 
MAM; 10% had multiple episodes of malnutrition with the most frequent combination 
being marasmus and MAM (5.4% of the children, table S1B). The average age at 
presentation with marasmus was 11±4 months; the corresponding ages for kwashiorkor 
and MAM were 16±7 and 14±7 months, respectively. Children with marasmus suffered 
significantly more episodes of diarrhea than did those with kwashiorkor or MAM 
(p<0.05; table S1C).  
The highest proportion of deaths was found in twin pairs discordant for 
marasmus compared to those discordant for kwashiorkor or MAM (p=0.0027, Chi-
square test): a co-twin died during the study in 43% of the twin pairs who were 
discordant for marasmus compared to 9% in twin pairs discordant for kwashiorkor and 
14% in those discordant for MAM (table S1A). The majority of deaths were attributed to 
diarrhea, malaria or pneumonia. In 120 of the 317 (37.9%) sampled families, at least one 
child (not a twin) had died at some point before our study; these deaths were not 
significantly more frequent in families of twins affected with SAM.  
There was no significant relationship between concordance for acute 
malnutrition and zygosity (table S1A), nor did we find significant differences in the 
number of MZ versus DZ twin pairs affected with kwashiorkor, marasmus, or MAM in 
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our cohort (table S1A, Chi-squared and Fisher’s exact tests). Taking all 135 discordant 
pairs into account, there was no statistically significant difference in the incidence of 
discordance for kwashiorkor, marasmus, or MAM in MZ versus DZ twin pairs (table 
S1A). In addition, we did not find any association between gender or geographic 
location and the type or incidence of malnutrition or in the discordance rate for MAM or 
SAM among twin pairs (Chi-squared and Fisher’s exact tests, table S1B,C).  
Metagenomic studies of the fecal microbiomes of same-gender twins discordant for 
kwashiorkor 
For the current study, we chose to focus on the microbiomes of children with 
kwashiorkor because survival of both members of a twin pair was significantly higher 
than with marasmus, onset occurred at a later age allowing us to better assess the state 
of maturation of the microbiome, the duration of RUTF treatment was more uniform 
than in cases of marasmus, and there was a lower incidence of relapse to SAM. Analysis 
of the microbiomes of children with marasmus will be the subject of another study. 
We selected 9 same gender twin pairs who remained well-nourished in our 
study cohort and 13 of 19 same gender twin pairs who became discordant for 
kwashiorkor for metagenomic analyses of their microbiomes [n=5 MZ and 4 DZ healthy 
pairs; 7 MZ and 6 DZ pairs discordant for kwashiorkor; for 12 of the 13 discordant pairs, 
there was a single episode of SAM during the study period; see table S2A for additional 
information about subjects and samples].  
Comparison of fecal microbiomes across healthy twin pairs and twin pairs discordant for 
kwashiorkor - Total fecal DNA was used for multiplex shotgun pyrosequencing (454 FLX 
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Titanium chemistry; n=308 samples). Reads were annotated by comparison to the KEGG 
database (table S2A) and to a database of 462 sequenced human gut microbes (table S3).  
To compare functional gene profiles across all 308 fecal samples, we calculated Hellinger 
distances from KEGG enzyme commission number (EC) assignments. Principal 
coordinates analysis (PCoA) of Hellinger distances was used to visualize variation in 
this dataset (Fig. 1A and fig. S1). Principal coordinate 1 (PC1), which explained the 
largest amount of variation (17%), was strongly associated with age and family 
membership (linear mixed-effects model, table S4).  Hellinger distances were calculated 
using KEGG ECs present in 93 fecal microbiome samples obtained from 9 healthy twin 
pairs surveyed between three weeks and 24.5 months of age. We found that on average 
the degree of intrapersonal variation in a co-twin was not smaller than the variation 
between co-twins (fig. S2). Similar to twins who remained healthy, the temporal 
variation within a co-twin member of a discordant twin pair was equal to the variation 
between co-twins, but still smaller than to unrelated children (fig. S2).  
Since age encompasses a variety of metabolic and dietary changes, we used the 
positions of microbiomes along PC1 in the KEGG EC-based PCoA plot to assess 
functional ‘maturation’ of the microbiomes of twin pairs who remained healthy and 
twin pairs who became discordant for kwashiorkor. When microbiomes from three 
consecutive time points from twins who remained healthy were plotted along PC1, there 
was a steady progression towards a more mature configuration (Fig. 1B). A similar 
result was observed in healthy co-twins from discordant twin pairs: fecal microbiomes 1 
month after cessation of RUTF were significantly more mature compared to before 
RUTF (p<0.05, Friedman test with Dunn’s post-hoc comparison; Fig. 1C). This was not 
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the case for their siblings with kwashiorkor: their fecal microbiomes, sampled prior to, 2 
and 4 weeks after initiation of, and 1 month following cessation of RUTF, did not show 
significant differences in their state of functional maturation (Fig. 1C).  
We examined differences in functional gene content in the fecal microbiomes of 
each discordant twin pair individually using Fisher’s exact test. To do so, the 
representation of KEGG ECs were compared between a healthy and malnourished co-
twin within each family at the time of presentation with kwashiorkor, two weeks into 
RUTF treatment, and 1 month after termination of RUTF. We did not identify any ECs 
that were significantly different across all 13 twin pairs; each discordant twin pair had a 
unique collection of ECs that were significantly different at each point of comparison 
(see table S5 for EC differences shared among subsets of the 13 twin pairs).  
These associations between the configurations of gut microbial communities and 
health status do not establish whether the microbiome is a causal factor in the 
pathogenesis of kwashiorkor. Moreover, because of the high intra- and interpersonal 
variation in the composition of the gut microbiome in the first three years of life, 
identifying the mechanisms by which gut microbiome may contribute to kwashiorkor is 
daunting. We have previously used metagenomic methods to show that a fecal 
microbial community from a single human donor can be replicated with a high degree 
of fidelity in multiple germ-free mouse recipients (14,15): these gnotobiotic animals can 
be given the same diets as those consumed by the donor, and can be followed over time 
under highly controlled environmental conditions that are not achievable in clinical 
studies. We reasoned that transplanting previously frozen fecal microbial communities, 
obtained from twin pairs at the time one of the co-twins presented with kwashiorkor, 
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would allow us to assess the degree to which donor phenotypes could be transmitted 
via their gut microbiomes, and to identify features of microbial community metabolism 
and host-microbial co-metabolism as a function of diet and microbiome donor.  
Transplantation and replication of fecal microbial communities from healthy and 
kwashiorkor co-twins in gnotobiotic mice  
When amplicons were generated from variable region 4 (V4) of bacterial 16S 
rRNA genes present in the pre-treatment fecal samples of co-twins in discordant pairs 
and subjected to sequencing with an Illumina HiSeq instrument (403,603±97,345 
reads/sample; table S2A), we did not find any phylum-, class-, order-, family-, genus or 
species-level taxa whose proportional representation were significantly different 
between healthy and kwashiorkor microbiota across all twin pairs.  In the absence of a 
distinct and consistent taxonomic signature of kwashiorkor, we selected pre-treatment 
fecal samples from three discordant twin pairs for microbiota transplants into adult 
germ-free C57BL/6J mice based on the following criteria: all twin pairs were roughly the 
same age, and neither co-twin in any pair had diarrhea, vomiting, or were consuming 
antibiotics at the time that fecal samples were collected. The twins selected included DZ 
pair 196 (aged 16.5 months), DZ pair 56 (aged 18 months), MZ twin pair 57 (aged 21 
months) (see fig. S4 and table S2A for clinical characteristics).  
Based on diet surveys of food ingredients and the frequency of their 
representation (9), we constructed a diet that reflected the staple foods consumed by 
individuals living in rural southern Malawi. The Malawian diet had low caloric density 
(1.0 kcal/g) and was deficient in multiple micro- and macronutrients as judged by 
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established nutritional recommendations for mice and for humans aged 1-3 (table S6). 
We also generated the peanut-based RUTF. Both diets were sterilized by irradiation. 
Phenotypic effects – Previously frozen, pre-treatment fecal microbiota from the 6 
selected human donors were each transplanted, with a single oral gavage, into separate 
groups of 8 week-old male germ-free C57BL/6J mice. Animals were placed on the 
Malawi diet beginning one week prior to gavage (n=5 mice cage; 5-10 
animals/treatment group; each treatment group maintained in a separate gnotobiotic 
isolator; diet given ad libitum; fig. S5). In the case of two of the three discordant twin 
pairs, transplantation of the kwashiorkor co-twin’s microbiota resulted in significantly 
greater weight loss in recipient mice over the ensuing 3 weeks than those harboring their 
healthy sibling’s microbiota. The discordance in weight loss was greatest for twin pair 
196 where recipients of the healthy co-twin’s microbiota maintained weight while those 
that received the kwashiorkor co-twin’s microbiota lost 33.9±9.4% of their pre-gavage 
body mass (Fig. 2A). In the case of family 57, mice harboring the kwashiorkor co-twin’s 
microbiota lost 20.0±9.3% of their body mass during this 3-week period, while recipients 
of microbiota from co-twins belonging to family 56 did not manifest a discordant 
phenotype (data not shown).  
Three weeks after gavage, mice were switched to RUTF. At the time of the diet 
switch, recipients of kwashiorkor microbiota from families 196 and 57 had become 
severely anorectic. All mice in each treatment group rapidly gained weight while 
consuming RUTF. In the case of the most discordant set of recipients (from family 196), 
mice with the kwashiorkor co-twin’s microbiota did not achieve the same body weight 
as recipients of the healthy sibling’s microbiota, but did reach 96.8%±2.8% of their pre-
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gavage weight (Fig. 2A). After two weeks on RUTF, all mice in all treatment groups 
were returned to the Malawian diet. While all recipients of microbiota transplants lost 
weight, this re-exposure did not produce the profound weight loss in mice colonized 
with the kwashiorkor microbiota that had been documented during their first exposure 
(Fig. 2A). These results indicate that the gut microbiota from two of the three discordant 
pairs are able to transmit a discordant malnutrition phenotype manifested by weight 
loss to recipient gnotobiotic mice. Given that the most discordant weight loss phenotype 
was produced by microbiota from twin pair 196, we initiated an in-depth analysis of 
their transplanted microbial communities. 
  The efficiency of transplantation of the kwashiorkor and healthy co-twin microbiota – 
Figure S5 shows the time points when samples were collected from gnotobiotic mouse 
recipients of microbiota transplants from discordant co-twins in family 196. Amplicons 
were generated from the V4 region of bacterial 16S rRNA present in the input human 
samples, as well as in the fecal microbiota of all mouse recipients, and sequenced 
(204,585±181,417 reads/sample; 10 recipients/microbiota; up to 8 time points 
surveyed/diet/mouse; n=379 samples; table S2B). DNA isolated from fecal samples 
collected at the end of each diet period was also subjected to shotgun pyrosequencing 
(n=54 samples; table S2C). Reads were assigned to KEGG ECs as above. 
Transplantation of the human donor microbiomes was quite efficient as judged 
by the representation of ECs in the input human fecal sample compared to their 
representation in ‘output’ fecal samples collected from each mouse in each recipient 
group three weeks post-gavage while they consumed the Malawian diet (90.6% and 
89.6% of the 859 ECs detected in each of the input communities from the healthy and 
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kwashiorkor co-twin donors, respectively, were identified in the fecal microbiota of 
transplant recipients). Moreover, the proportional representation of ECs in the fecal 
communities of the donors was highly correlated with their proportional representation 
in the fecal microbiota of transplant recipients (R2=0.893-0.936; fig. S6A,B).  
Table S7A,B provides species-level data from the V4-16S rRNA datasets 
generated from the fecal microbiota of mice harboring the transplanted family 196 
microbiota. Sixty-two of the 72 species-level taxa present in the input community from 
the healthy co-twin were detected in fecal microbiota collected from all transplant 
recipients across time and diets. Fifty-eight of the 67 species level taxa were found in the 
case of the kwashiorkor co-twin transplant.  
We used established PCR-Luminex assays (16-19) to test for 22 common 
bacterial, parasitic, and viral enteropathogens in the input human microbiota as well as 
in recipient mouse fecal samples. Microbiota of members of this family (and the other 
discordant pair from family 57) harbored protozoan (Giardia and Cryptosporidium) as 
well as bacterial pathogens [Campylobacter, atypical enteropathogenic E. coli (EPEC), 
enterotoxigenic E. coli (ETEC), and enteroinvasive E. coli/Shigella]. This diversity and 
multiplicity of enteropathogens is not surprising in children from low-income countries 
(20).  The presence of several enteropathogens appeared to cluster within the families 
(e.g., Giardia, atypical EPEC, ETEC, Shigella/EIEC, and Campylobacter); however, levels 
were not significantly different between the healthy and kwashiorkor co-twins (two-way 
ANOVA with Bonferroni post-test; fig. S7A). Atypical EPEC and ETEC, detectable in 
the fecal microbiota of both co-twins in family 196, were transferred to recipient 
gnotobiotic mice but cleared rapidly (fig. S7B). Cryptosporidium DNA was present at 
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high levels in the kwashiorkor co-twin from family 196 but was only detected at two 
time points in one of the gnotobiotic recipients (fig. S7C). We concluded that the 
markedly discordant weight loss phenotype in recipients of these microbiota did not 
simply track with the enteropathogen DNA findings.  
The effect of diet on the configuration of transplanted microbiota from family 196  - 
Comparing the two groups of gnotobiotic transplant recipients on a Malawian diet 
disclosed significant differences in the proportional representation of 37 species-level 
taxa. Organisms with the most statistically significant differences, and whose relative 
proportion were higher in mice with the kwashiorkor microbiota were Bilophila 
wadsworthia, a hydrogen-consuming, sulfite-reducing Proteobacteria related to members 
of Desulfovibrio, that is associated with appendicitis and inflammatory bowel disease 
(IBD) in humans, and induces a pro-inflammatory T-helper 1 response in a mouse model 
of IBD (21-25), and Clostridium innocuum, a gut symbiont that can function as an 
opportunist in immunocompromised hosts (26) (table S8B). B. wadsworthia and members 
of the order Clostridiales were also overrepresented in the fecal microbiota of the 
kwashiorkor co-twin from family 196 compared to his healthy co-twin at the time he 
presented with SAM (table S8B).  
 Switching from a Malawian diet to RUTF produced a rapid change in 
configuration of the fecal microbiota. This change was most pronounced in recipients of 
the kwashiorkor co-twin’s community (see PC1 in the PCoA plot of weighted UniFrac 
distance measurements in Fig. 2B and fig. S8A,B). Thirty species-level taxa exhibited 
significant changes in their representation in kwashiorkor microbiota transplant 
recipients (Fig. 2C, tables S7B and S8A) with prominent increases in Bifidobacteria (B. 
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longum, B. bifidum, plus another unclassified taxon or taxa), two Lactobacilli [L. reuteri and 
L. gasseri, which can produce bacteriocins and stimulate the innate immune system to 
inhibit the growth and eliminate various enteropathogens (27-33)], plus two members of 
Ruminococcus [R. torques, a mucus degrader (34), and Faecalibacterium prausnitzii, a 
member of the order Clostridiales that exhibits anti-inflammatory activity in a mouse 
model of colitis, and whose decreased representation is associated with increased risk of 
ileal Crohn’s disease (35)]. There were statistically significant decreases in the 
representation of members of the Bacteroidales (B. uniformis, Parabacteroides distasonis, 
plus an unclassified Parabacteroides taxon or taxa). 
The time courses of these responses differed. The bloom in Lactobacilli occurred 
early during treatment with RUTF but regressed by the end of this diet period and 
remained unchanged when animals returned to the Malawian diet. The Bifidobacterium 
spp also bloomed early during administration of RUTF. Unlike the Lactobacilli, their 
increase was sustained into the early phases of the second Malawian diet period (M2) 
after which they diminished. Like the members of Bifidobacterium, R. torques increased its 
representation during RUTF and then rapidly diminished when mice returned to a 
Malawian diet. The increase in F. prausnitzii was sustained into and through M2. The 
responses of the Bacteroidales were opposite to that of the other three groups: they 
decreased with RUTF and re-emerged with M2 (Fig. 2C, tables S7B and S8A).  
Twenty-eight bacterial species-level taxa exhibited significant changes in their 
representation in gnotobiotic mice harboring the healthy co-twin’s microbiota in 
response to RUTF. The response of the Lactobacilli observed in the kwashiorkor 
transplant recipients was not seen in gnotobiotic mice containing the healthy co-twin’s 
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microbiota. The pattern of change of 13 different taxa including the two Ruminococcus 
spp., B. uniformis, P. distasonis, B. longum and an unclassified Bifidobacterium taxon or taxa 
were shared by both recipient groups (healthy and kwashiorkor), although the 
Bifidobacterium response was more diminutive in the healthy microbiota treatment group 
(Fig. 2C, tables S7A and S8A,B). These changes were representative of those that 
occurred in the human donors: members of Ruminococcus increased with RUTF in both 
co-twins, while the change in Bifidobacterium was unique to the kwashiorkor co-twin 
(table S9).  
Responses that were specific to mice containing the healthy co-twin’s microbiota 
included increases in Parabacteroides merdae, an unclassified taxa or taxon from the genus 
Faecalibacterium, as well as an unclassified taxa or taxon from the family Coriobacteriaceae 
when mice switched to a RUTF diet. Of these, only Parabacteroides merdae did not persist 
when animals were returned to the Malawian diet (Fig. 2C, table S7A and S8A).  
Effect of diet on the metabolic profiles of transplanted kwashiorkor and healthy co-twin 
microbiomes from family 196 – We performed targeted GC-MS analyses of short chain fatty 
acids (SCFA), and non-targeted GC-MS of 69 other products of carbohydrate, amino 
acid, nucleotide and lipid (fatty acid) metabolism in fecal samples collected 10 and 16 
days after gavage during the first Malawian diet phase (M1), 2 and 10 days after 
switching to RUTF, and 26 days after return to the second Malawian diet phase (M2) 
(n=4-5 mice/family 196 microbiota donor). PCoA plots, based on Hellinger distance 
measurements of fecal metabolite profiles, revealed a marked effect of RUTF in both 
groups of mice (see PC1 in fig. S9A). PC2 disclosed a donor microbiota effect, with a 
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prominent difference between recipient groups evident after the switch from RUTF back 
to a Malawian diet (fig. S9B).  
Figure S9C displays metabolites that exhibited statistically significant differences 
in their levels in both groups of transplant recipients when they were consuming RUTF 
versus the Malawi diet (p<0.05; unpaired Student’s t-test). Levels of the majority of 
metabolites, including amino acids, fatty acids, and products of nucleotide metabolism, 
increased when mice were switched to RUTF. In contrast, levels of several di- and 
monosaccharides (maltose, gentibiose and tagatose) decreased.  
There were a number of significant differences in metabolite levels in feces 
harvested from mice containing the transplanted kwashiorkor versus healthy co-twin 
microbiota while they were consuming the different diets (Fig. 3). For example, 
switching to RUTF produced a significant increase in levels of 6 essential amino acids 
(valine, leucine, isoleucine, methionine, phenylalanine, threonine) and 3 nonessential 
amino acids (alanine, tyrosine, serine) in both groups of mice (fig. S10A,B). However, in 
the kwashiorkor group, the response was initially greater but subsequently diminished 
and was surpassed by the increase observed in mice with the healthy co-twin’s 
microbiota. Four weeks after returning to a Malawian diet, levels of 6 of these amino 
acids remained higher in the healthy microbiota recipient group than before RUTF. In 
contrast, in the kwashiorkor group they fell to pre-RUTF treatment levels (fig. S10A,B). 
The same pattern of transient response was observed with urea cycle intermediates in 
the kwashiorkor group (fig. S10C). Targeted GC-MS of SCFA showed a significant 
RUTF-associated increase in levels of propionate, butyrate, lactate and succinate in both 
groups of mice: this increase was rapid, confined to the early period of RUTF 
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consumption, and was generally greater in mice harboring the healthy co-twin’s 
microbiota (fig. S11A). Acetate levels in the healthy but not the kwashiorkor microbiota 
group showed the same pattern of change (fig. S11A). Increases in these end products of 
fermentation were accompanied by reductions in the levels of a number of mono- and 
disaccharides (fig. S11B). The observed differences in metabolic profiles were not 
attributable to differences in microbial community biomass: there were no statistically 
significant differences in fecal DNA content between the two groups of mice when 
assayed at the midpoint of RUTF treatment or 4 weeks after cessation of treatment (data 
not shown).  
Procrustes analysis of data obtained from the transplanted microbiota from 
discordant co-twins in family 196 (fig. S12) revealed significant correlation between 
metabolic and taxonomical profiles on each diet with an overall goodness of fit (M2 
value) of 0.380 (p<0.0001; 1,000 Monte Carlo label permutations) for all diets and 
microbiota.  
Shared microbial responses between mice receiving transplants from discordant pairs 196 
and 57 – As in the case of discordant twins belonging to family 196, transplantation of 
fecal microbiota from discordant twin pair 57 was highly efficient. Only 4 of 69 and 2 of 
76 species-level taxa detected in the input community were not detected in the output 
fecal microbiota of healthy and kwashiorkor co-twin microbiota transplant recipients, 
respectively (table S7C,D). Moreover, 87.4-92.3% of the 835 ECs present in the input 
communities were detected in the recipient mice, and the proportional representation of 
these ECs in the input and ‘output’ fecal samples was highly correlated (R2=0.784-0.859; 
fig. S6C,D). 
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Thirty-three species-level taxa were identified whose proportional representation 
was significantly different in the fecal microbiota of the two groups of family 57 
transplant recipients when they were consuming a Malawian diet (table S8D). Six of 
these taxa showed corresponding significant differences in recipients of the discordant 
twin pair 196 microbiota (noted in bold font in table S8D). Taxa that showed higher 
proportional representation in both sets of mice with the kwashiorkor microbiota 
included Bilophila wadsworthia, Dorea formicigenerans, a producer of formate used by 
sulfur-reducing bacteria (36), Coprococcus comes, a Firmicute associated with Crohn’s 
disease (37), plus an unclassified Bacteroidales taxon or taxa. Examining 16S rRNA data 
generated from the human fecal samples prior to transplantation, we found that as with 
family 196, B. wadsworthia, as well as members of the order Clostridiales (Coprococcus 
comes, Dorea formicigenerans), and the order Bacteroidales were overrepresented in the 
microbiota of the kwashiorkor co-twin in family 57 compared to the well-nourished 
sibling (table S8B,D).  
Like family 196 recipient mice, switching from the Malawian diet to RUTF 
produced a rapid change in microbiota configuration, with the family 57 kwashiorkor 
microbiota recipients exhibiting a more dramatic change than recipients of the healthy 
sibling’s microbiota (fig. S8C,D). Moreover, the kwashiorkor gut community underwent 
many of the same changes seen with the family 196 kwashiorkor sample, including 
changes in Bifidobacterium (B. longum, B. bifidum and another unclassified taxa or taxon), 
R. torques, and Bacteroidales (B. uniformis, Parabacteroides distasonis and an unidentified 
Parabacteroides taxa or taxon) (tables S7D and S8C). Table S9 compares common 
changes observed in mice and in twins in families 196 and 57 to changes noted in the 
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other 11 discordant twin pairs as a function of health status and diet; e.g., Collinsella 
aerofaciens, Coprococcus comes, Ruminococcus obeum, Dorea formicigenerans and 
Bifidobacterium longum showed similar patterns in most twin pairs.  
GC-MS of mouse fecal samples, collected on the last day of each diet period, 
revealed a very similar metabolic profile to that seen in mice who had received 
transplants from discordant pair 196, with essential and non-essential amino acids, fatty 
acids, and products of nucleotide metabolism manifesting statistically significant 
differences in their levels when mice were consuming RUTF versus the Malawian diet 
(fig. S13, p<0.05; unpaired Student’s t-test).  
Microbial-host co-metabolism as a function of donor microbiota and host diet  
Untargeted urine metabolite profiles were obtained from mice that were the 
recipients of microbiota transplants from discordant twin pairs using standard 1H NMR 
spectroscopic analysis (38). The initial global metabolite profiles from samples obtained 
during the M1 diet period were significantly different between mice transplanted with 
the kwashiorkor versus the healthy co-twin microbiota. For discordant twin pair 196, the 
kwashiorkor microbiota was associated with higher levels of urinary allantoin (an end 
product of purine metabolism in non-primates, equivalent to uric acid in humans), 
creatine and creatinine (markers of muscle turnover), and dimethylamine (linked to gut 
microbial metabolism of choline via trimethylamine). Lower urinary concentrations of 2-
oxoadipate (a product of lysine metabolism) and trimethylamine (from choline) were 
also noted (table S10). Mice harboring transplanted microbiota from kwashiorkor co-
twin 57 also showed increased urinary excretion of allantoin, creatine and 
dimethylamine. Increased excretion of phenylacetylglycine (microbial-host co-
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metabolite from colonic phenylalanine metabolism), trimethylamine-N-oxide 
(alternative metabolic product of trimethylamine derived from choline), and acetate 
were characteristic for mice harboring the microbiota for kwashiorkor co-twin 57; these 
latter differences were not significant in recipients of the discordant family 196 twin 
microbiota although there was a trend towards increased trimethylamine-N-oxide 
excretion in mice harboring the kwashiorkor community. 
Levels of urinary taurine were affected by both donor microbiota and diet. Mice 
harboring a healthy donor microbiota excreted more taurine while consuming both the 
Malawian diet and RUTF compared to mice with a kwashiorkor microbiota; in both 
groups, urinary taurine levels were higher when mice were consuming a Malawian diet 
(table S10). B. wadsworthia grows well on bile acids and uses taurine from taurine-
conjugated bile acids as a terminal electron acceptor, converting it to ammonia, acetate 
and sulfide (39). In agreement with this property, fecal levels of B. wadsworthia showed 
an inverse relationship with urinary taurine levels, falling in mice harboring the 
kwashiorkor co-twin microbiota from 5.1% during the M1 diet phase to 1.9% on RUTF 
and rising to 2.1% during the M2 diet period; in contrast, levels remained <0.1% in mice 
with the healthy sibling’s microbiota (table S8A,B).  
Figure 4A shows how RUTF had a dominant effect on metabotype as evidenced 
by the apparent clustering of urine samples from mice colonized with microbial 
communities from the family 196 twin pair, whereas urine samples from the healthy and 
kwashiorkor groups showed a clear distinction when mice were consuming the 
Malawian diet. However, a separate PCA model of urine samples obtained during the 
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RUTF dietary period (Fig. 4B) reveals differences between healthy and kwashiorkor 
microbiota transplant recipients.  
The pronounced metabolic shift in response to the RUTF diet was not sustained 
on re-introduction of the Malawian diet; metabolic profiles at the end of the M2 period 
resembled those from M1, with renewed differentiation of the healthy versus 
kwashiorkor microbiota transplant groups, although the kwashiorkor microbiota-
associated metabolic phenotype was not as distinctive as with M1 (Fig. 4C). When the 
data were remodeled excluding the RUTF samples, metabolic differentiation was more 
apparent between the two Malawian dietary periods and between mice harboring the 
healthy versus kwashiorkor co-twin microbiota, with relatively greater differentiation 
observed between healthy and kwashiorkor in M1 (Fig. 4C).  
Differences between healthy and kwashiorkor microbiota from discordant twin 
pair 196 were also observed in the plasma metabolome (Fig. 4D) with higher glucose 
concentrations and lower levels of citrate, acetate, lactate and tyrosine in mice harboring 
the healthy co-twin’s microbiota. 
In the case of mice containing the healthy co-twin’s microbiota, the urinary 
excretion behaviors of the tricarboxylic acid (TCA) cycle intermediates 2-oxoglutarate, 
citrate, succinate and fumarate were closely coupled together when mice were compared 
during the M1 versus RUTF, RUTF versus M2, and M1 versus M2 diet periods. 
Similarly, they were closely coupled when healthy versus kwashiorkor transplant 
recipients were compared during the M1 or RUTF or M2 periods (table S10). It is known 
that these mitochondrial metabolites typically follow similar reabsorption control 
mechanisms in the renal tubule that are closely linked to tubular pH. Under conditions 
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of renal tubular acidosis, renal mitochondria utilize the intermediates at a higher rate 
and, consequently, a greater proportion of these intermediates are reabsorbed from the 
urine, driven by the concentration gradient. In mice colonized with the kwashiorkor but 
not the healthy microbiota, fumarate excretion was effectively decoupled from the other 
TCA intermediates (table S10). Such differential excretion rates of TCA intermediates 
can occur where there is selective enzymatic inhibition of the TCA cycle (40). There also 
appears to be a disruption in the TCA cycle in the microbiota with significantly 
increased levels of succinate  (3-fold, p<0.05, unpaired Student’s t-test), and an increased 
succinate to fumarate ratio (0.58 versus 0.23, p<0.05, unpaired Student’s t-test) in cecal 
samples from the kwashiorkor recipient mice, suggesting inhibition of succinate 
dehydrogenase, the enzyme responsible for converting succinate to fumarate. Taken 
together, these observations suggest that the kwashiorkor microbiota examined in these 
gnotobiotic mice may generate chemical products that result in a selective inhibition of 
one or more TCA cycle enzymes, with concomitant effects on host energy metabolism. 
This hypothesis warrants further study, first in humanized gnotobiotic mice and 
subsequently in discordant twins. 
Prospectus 
The observation that discordance rate for kwashiorkor is so high in twins in our 
study population, and that no statistically significant difference exists in discordance 
rates between mono- versus dizygotic twins, focuses attention on the need to delineate 
the impact of environmental exposures on the pathogenesis of this enigmatic disease: 
this includes a systematic analysis of maternal and infant characteristics. Our results 
illustrate the value of studies using twins discordant for nutritional phenotypes to 
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characterize the interrelationship between the functional development of the gut 
microbiota in children and their nutritional status. Linking metagenomic analyses of the 
compositional features of these communities to their subsequent transplantation and 
replication in groups of gnotobiotic mice who are fed diets representative of those 
consumed by the human microbiota donors, has provided evidence that the microbiota 
is likely a causal factor in the pathogenesis of kwashiorkor. By replicating a human 
donor’s microbiota in multiple recipient gnotobiotic mice and subjecting the mice to the 
same therapeutic dietary manipulations as those experienced by human donors, but 
under more controlled conditions, we have been able to mimic a clinical intervention, 
identify community characteristics, including differences in taxonomic composition and 
differences in taxonomic and metabolic responses to RUTF, that are informative at 
several levels. First, they provide biomarkers of community metabolism and of 
microbial-host co-metabolism that delineate and discriminate diet and microbiota 
effects, including biomarkers indicative of the more labile, short-lived nature of the 
responses of microbiota from kwashiorkor donors to RUTF. These discriminatory 
biomarkers can serve as the basis for more detailed studies of  microbiota samples 
obtained from the human donors used to create the mouse model, as well as larger 
population studies. Second, these mice provide insights about pathogenesis by 
identifying transmissible features of the community, including those that are diet-
associated, thereby distinguishing casual versus causal relationships between microbiota 
and human host phenotypes. Although beyond the scope of the present study, the 
interrelationships between diet, microbiota, and many facets of host physiology can be 
explored in detail in these ‘personalized’ gnotobiotic mouse models, such as how the 
combination of a given diet and microbiota influences functional properties of the innate 
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and adaptive arms of the immune system, overall energy homeostasis, or neurologic 
functions. Third, these models may not only provide a way for identifying different 
pathogenetic mechanisms and distinguishing disease subgroups, but also for developing 
new and more effective approaches for treatment and/or prevention. On the one hand, 
the effects of different therapeutic diets, formulated based on metabolic deficiencies 
observed in these gnotobiotic mouse models, can be systematically evaluated, including 
whether their long-term administration can repair metabolic dysfunctions associated 
with the gut communities from malnourished individuals, whether their effects are 
generalizable to microbiota transplanted from donors representing different geographic 
locations, and whether the reconfiguration of community properties they produce can 
be sustained after withdrawal of treatment. On the other hand, these models can help 
identify lead probiotic species, especially given recent advances that allow an extensive 
culture collection to be generated from an intact uncultured microbiota once that 
microbiota is observed to transmit a phenotype to recipient mice (15). In addition, 
characterization of microbial-host co-metabolism can yield testable hypotheses about 
potential host therapeutic targets. For example, an intriguing hypothesis, based on 
measurements of cecal and urinary levels of TCA cycle intermediates is that a 
kwashiorkor microbiota, when exposed to a Malawi diet, may produce one or more 
inhibitors of mitochondrial TCA cycle enzymes, making energy metabolism a bigger 
challenge for these children when they are exposed to a micro- and macronutrient 
deficient, low calorie diet. Finally, studies of other forms of malnutrition using an 
approach analogous to that described in this study, could also help provide insights 
about the contribution of gut microbiota to this devastating global health problem.   
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Figure #:  
Fig 1.  Functional maturation of the gut microbiomes of Malawian twin pairs 
concordant for healthy status, and twin pairs who became discordant for 
kwashiorkor. (A) PCoA of Hellinger distances between KEGG EC profiles. The position 
of each fecal microbiome along principal coordinate 1 (PC1), which describes the largest 
amount of variation in this dataset of 308 sequenced twin fecal microbiomes, is plotted 
against age. Each sphere represents a microbiome colored by the age of the human 
donor. (B) Average ± SEM PC1 coordinate obtained from the data shown in panel A for 
microbiomes sampled at 3 consecutive time points from 9 twin pairs who remained 
well-nourished (healthy) during the study. (C) Average ± SEM PC1 coordinate obtained 
from panel A for microbiomes sampled before, during and after RUTF treatment from 
co-twins discordant for kwashiorkor. *p<0.05, Friedman test with Dunn’s post-hoc test 
applied to data shown in panels B and C. [See fig. S3 which shows how changes in the 
relative proportion of Actinobacteria parallel the patterns observed with the changes 
along PC1; children with kwashiorkor manifested a statistically significant decrease in 
Actinobacteria with introduction of RUTF, unlike their healthy co-twins (p<0.05 after 
FDR correction for comparison of other bacterial phyla]. 
Fig 2.  Transplantation of fecal microbiota from kwashiorkor and healthy co-twins 
from family 196 into gnotobiotic mice fed Malawian and RUTF diets. (A) Discordant 
weight loss phenotype of recipient mice, n=10 mice/group, *p<0.05, Student’s t-test. 
Data points are colored by recipient group; blue, kwashiorkor co-twin fecal microbiota 
recipients; red, healthy co-twin fecal microbiota recipients. (B) Average ± SEM PC1 
coordinate obtained from the weighted UniFrac distances shown in fig. S8A for fecal 
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microbiota sampled from mice over time. Same color key as in panel A. (C) Heatmap of 
species-level taxa whose representation in the fecal microbiota of gnotobiotic mice 
change significantly (p<0.05, Students t-test with Bonferonni correction) as a function of 
donor microbiota and Malawian versus RUTF diets. An asterisk indicates taxa that 
changed significantly in both groups of microbiota transplant recipients. Species level 
taxa are colored by phylum; Firmicutes (red), Actinobacteria (blue), Bacteroidetes (black) 
and Proteobacteria (green).  
Fig. 3.  Metabolites with significant differences in their fecal levels in gnotobiotic 
mice colonized with microbiota from discordant twin pair 196 as a function of diet. 
Data are from fecal samples collected 3 days before the end of (A) the first period of 
consumption of the Malawian diet (M1, day 16; abbreviated M1.D16), (B) RUTF 
treatment (RUTF.D10), (C) the second period of Malawian diet consumption (M2.D26). 
Significant differences are defined as p<0.05 according to Student’s t-test.  
Fig. 4.  Principal component analysis (PCA) scores plots derived from 1H-NMR 
analysis of urine obtained from mice with microbiota transplants from discordant 
twin pair 196. (A) PCA plot of all urine samples from both groups of mice over the three 
dietary periods emphasizing the impact of RUTF. (B) PCA plot of samples collected 
during the RUTF phase, emphasizing differences between mice harboring healthy and 
kwashiorkor co-twin microbiota. (C) PCA plot excluding samples collected during the 
RUTF phase, emphasizing differences between mice harboring healthy and kwashiorkor 
co-twin microbiota and between the two Malawian diet periods. (D) PCA lot of plasma 
samples collected at the end of the second Malawi diet (M2) phase, showing the 
difference in plasma metabolite profiles between mice harboring healthy (filled squares) 
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and kwashiorkor (open squares) co-twin microbiota. All datasets were aligned, 
normalized to total area, centered and log 2 transformed with an offset of 1.  
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Materials and Methods 
Studies in humans  
Enrollment, clinical data and sample collection - Subjects were recruited for the 
present study using procedures approved by the College of Medicine Research Ethics 
Committee of the University of Malawi, and by the Human Research Protection Office of 
Washington University in St. Louis. Twin pairs were recruited through health centers 
located in five rural southern Malawian villages. A team of one USA pediatrician and a 
minimum of two trained local personnel visited each site every month where the weight 
and height of each infant or child was measured in three replicates, and each child was 
checked for bilateral pitting edema. RUTF was produced in Malawi (41). On average, 
twin pairs where one or both co-twins developed kwashiorkor received 9±8 (mean ± SD) 
weeks of RUTF treatment, while those with marasmus were treated for 11±8 weeks. 
During each visit for a scheduled fecal sample collection, each child wore a 
commercial disposable diaper lined with plastic. Each fecal specimen was frozen within 
10 min after it was produced in a cryogenic storage container filled with liquid nitrogen. 
All samples were subsequently stored at -80oC prior to analyses.  
Zygosity tests - Buccal smears were collected using Oragene kits. We selected 48 
autosomal SNPs with high heterozygosity in the Yoruban HapMap sample (n=90) from 
the Illumina DNA Test Panel of 360 SNP loci that have been optimized for the 
BeadExpress. The SNP minor allele frequencies in Yorubans ranged from 0.28-0.43, and 
each autosome was sampled by at least one marker (with the exception of 7,19 and 21), 
with a minimum marker separation of 3Mb. We ran PREST [Pedigree Relationship 
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Statistical Test (42)] to estimate the identity-by-descent sharing and kinship between the 
relative pairs, and compared reported relationships versus the inferred relationships 
from the genetic data. 
Isolation and sequencing of fecal microbial community DNA - Fecal samples from 
humans were pulverized with a mortar and pestle in liquid nitrogen. DNA was 
extracted from aliquots of the pulverized material (43). Amplicons, generated by PCR of 
bacterial 16S rRNA genes present in the fecal DNA samples were subjected to multiplex 
sequencing with an Illumina HiSeq instrument using procedures described in a previous 
publication (44). Multiplex shotgun 454 Titanium FLX pyrosequencing of each fecal 
community DNA sample was conducted according to ref. (9). 
Analysis of metagenomic datasets 
16S rRNA – We used QIIME (45) to cluster V4-16S rRNA Illumina reads at 97% 
nucleotide sequence identity (%ID). Closed-reference OTU picking protocol with uclust 
against the Greengenes database was employed. Reads that did not match the database 
were excluded from further analyses. Of the 110,819,831 Illumina reads that passed 
QIIME's quality filters, 93.5% (103,583,462) hit a reference sequence at greater than or 
equal to 97% ID. Taxonomy was assigned using RDP classifier 2.4. UniFrac distances 
between samples were calculated using a de novo tree constructed from representative 
sequences defining each OTU. A table of OTU counts per sample was generated and 
used in combination with the tree to calculate beta diversity. To generate UniFrac 
distance matrices, all communities were rarefied to 116,440 V4-16S rRNA reads/sample. 
Unweighted UniFrac rather than weighted UniFrac was used for our analyses due to the 
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large differences in taxonomic representation among the samples. Nonetheless, the 
patterns were similar with weighted UniFrac (data not shown).  
Shotgun sequences from fecal microbiomes - Shotgun reads produced by 454 
Titanium shotgun sequencing were filtered using custom Perl scripts and publicly 
available software to remove (i) all reads <60 nt, (ii) reads with two continuous and/or 
three total degenerate bases (N), (iii) all duplicates (a known artifact of pyrosequencing), 
defined as sequences whose initial 20 nucleotides are identical and that share an overall 
identity of >97% throughout the length of the shortest read (46); and (iv) all sequences 
with significant similarity to human or mouse reference genomes (Blastn e-value 
threshold < 10-5, bitscore > 50, percent identity > 75%). In addition, searches against a 
database of the 462 human gut bacterial genomes (listed in the table S3) were conducted 
with megablast. A sequence read was annotated as the best hit to this database if the E-
value was <10-20, and at least 90% identical between query and subject. The relative 
abundances of reads that mapped to each of the 462 genomes were adjusted to genome 
sizes. For sequences that mapped to more than one genome, counts were adjusted 
according to unique matches using a previously described procedure (47): for example, 
in the case of a non-unique read that equally matched genome A and genome B, and 
where two unique reads matched genome A and eight unique reads matched genome B, 
0.2 counts would be assigned to genome A and 0.8 counts to genome B.  
Searches against protein-coding component of the KEGG database (version 58) 
were conducted with BLASTX. Counts were normalized to the mapped reads. 26±4% of 
the reads mapped to KEGG ECs and 55±14% to the 462 reference human gut genomes. 
Unmapped reads were excluded from the analyses shown, although repeating the 
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analyses including these reads had little effect on the results. To quantify the differences 
in KEGG EC profiles among fecal microbiomes, evenly rarefied matrices of EC counts 
were created with all samples, and Hellinger distances were calculated using QIIME. T-
test and linear mixed-effects regression analyses were conducted in R statistical software 
using package NLME (48) for the latter analysis. 
Studies in gnotobiotic mice 
Colonization of germ-free animals  
All experiments involving mice were performed using protocols approved by the 
Washington University in St. Louis Animal Studies Committee. Germ-free 8 week-old, 
male C57BL/6J mice were maintained in flexible plastic gnotobiotic isolators (Class 
Biologically Clean Ltd., Madison, WI) under a strict 12-hour light cycle (lights on at 
0600h) and fed ad libitum. Transplantation of human fecal microbiota was performed by 
first pulverizing the frozen fecal sample with mortar and pestle in liquid nitrogen. 
Approximately 200 mg of the pulverized sample was diluted in 4 mL of sterile 
PBS/2mM DTT at room temperature in an anaerobic chamber (Coy Lab Products, Grass 
Lake, MI; atmosphere composed of 75% N2/20% CO2/5% H2). The fecal material was 
suspended by vortexing (3 min at room temperature) and the resulting suspension was 
allowed to settle by gravity (2 min at room temperature in the anaerobic chamber). The 
supernatant was placed in a sterile polypropylene tube that was capped and placed in a 
Balch tube. The Balch tube was then capped, taken out of the Coy chamber and 
transported, at room temperature, to our gnotobiotic mouse facility (~10 minute-long 
trip). The polypropylene tube was then removed from the protective Balch tube, placed 
in a transfer sleeve attached to the gnotobiotic isolator and its external surface was 
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sterilized during a 20 min exposure to 2% chlorine dioxide. Once introduced into the 
gnotobiotic isolator, the tube was opened, and a ~200 μL aliquot was gavaged, using a 
flexible plastic tube attached to a sterile syringe, directly into the stomach of each germ-
free recipient mouse (n=5-10 mice per donor microbiota preparation).  
All mice that received a fecal microbiota sample from a given human donor were 
co-housed (n=5/cage) in a given gnotobiotic isolator. Different isolators were used for 
different donors. The sterility of germ-free mice and their isolators was established by 
routine culture-based surveys of fecal samples as well as by PCR of fecal DNA using 
universal bacterial 16S rRNA primers. 
Preparation of human diets given to gnotobiotic mice 
Ingredients for constructing a representative Malawi diet, and the peanut-based 
RUTF, were purchased from vendors in the USA. Meseca instant corn flour was 
obtained from Restaurant Depot (College Point, NY). Organic mustard greens, yellow 
onions and vine-ripened tomatoes were purchased fresh from Whole Foods 
Supermarkets. Ground peanuts were from East Wind Nut Butters (Tecumseh, MO).  
Food was prepared in 18 kg batches. Four kilograms of corn flour were added to 
12.3 liters of freshly autoclaved water and blended for 5 min using an industrial mixer 
(Globe SP30P 30-quart pizza mixer; gear speed 1; Globe Food Equipment Company, 
Dayton, OH). This step was followed by addition of 1.63 kg of a relish. This relish was 
produced by adding 770 g of mustard greens to 154 g of yellow peeled onions, 385 g of 
vine-ripened tomatoes and 321 mL of water. The mixture was then pureed for 10 min in 
a vertical cutter mixer (Robot Coupe Model R23, Jackson, MS) and simmered for 30 min 
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on a Corning stirrer/hot plate (high setting) prior to addition to the corn-water solution. 
Following addition of the relish, food was blended in the mixer for 5 min. Two to three 
batches of food were prepared in succession over the course of a day, with each batch 
being temporarily stored in covered plastic containers. At the end of the day, subsets of 
each batch were mixed together so that there was a homogeneous product. The finished 
product was then vacuumed packed in 500 g aliquots in FDA/USDA-compliant poly-
nylon vacuum pouches, double-bagged, and sterilized by irradiation (20-50 kGy) within 
24 h of its production (Steris Co; Chicago, IL). The macro- and micronutrient content of 
the cooked and irradiated Malawian diet was defined by N.P. Analytical Laboratories 
(St Louis, MO) (table S6). Food was stored at 4oC for up to six months. Sterility was 
verified using the same culture methods employed to survey gnotobiotic isolators (see 
above).  
Peanut-based RUTF was produced by Harlan Laboratories (Madison, WI) using 
a recipe described in a previous publication (41). RUTF was packaged and sterilized as 
above. 
Plastic bags containing 500 g of a given diet were introduced into each 
gnotobiotic isolator after sterilizing the external surface with 2% chlorine dioxide. A 
small incision was placed at one corner of each bag so that the food, which had the 
consistency of paste, could be extruded into sterilize glass petri dishes placed in two 
locations in each cage. Food was refreshed twice per day, allowing for ad libitum feeding. 
Sample collection  
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Fecal samples collected from mice were frozen and stored -80oC within 30 min of 
their production. Fecal and urine samples collected for metabolomic analyses were 
frozen in liquid nitrogen within 2-10 min after they were produced and subsequently 
stored at -80°C. Just prior to sacrifice, blood was obtained by retro-orbital phlebotomy.  
Isolation and sequencing of fecal DNA 
Isolation of fecal DNA, bacterial V4-16S rRNA amplicon and whole community 
shotgun sequencing, and analyses of the resulting datasets were conducted as described 
above for human samples. 
qPCR assays for enteropathogens 
 DNA isolated from human donor fecal samples and mouse fecal pellets was 
tested for 22 enteropathogens using a custom, multiplex, reverse transcription PCR 
Luminex assay (16-19) for detecting Adenovirus, Ancylostoma duodenale, Ascaris 
lumbricoides, Campylobacter jejuni/coli, Cryptosporidium spp., Cyclospora cayetanensis, 
Cystoisospora belli, Enterocytozoon bieneusi, Encelphalitozoon intestinalis, enteroaggregative 
E. coli (EAEC), enterohemorrhagic E. coli (EHEC), enteropathogenic E. coli (EPEC), 
enterotoxigenic E. coli (ETEC), enteroinvasive E. coli (EIEC)/Shigella spp.,  Entamoeba 
histolytica, Giardia lamblia, Necator americanus, Salmonella spp., Strongyloides stercoralis, 
Trichuris trichiura, Vibrio cholera/parahaemolyticus and Yersinia spp.  Atypical EPEC was 
inferred if eae was present without bfpa (characteristic of typical EPEC) or stx1/stx2 
(present with EHEC).  Our assay for the heat-stable enterotoxin of ETEC detects STh, 
while ipaH detects but does not discriminate between enteroinvasive E. coli (EIEC) and 
Shigella spp. 
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Metabolomic analyses 
Targeted gas chromatography-mass spectrometry - Fecal pellets were weighed in 2 
mL polytetrafluoroethylene (PFTE) screw cap vials. A mix of internal standards (20μM 
of acetic acid-13C2,d4, propionic acid-d6, butyric acid-13C4, lactic acid-3,3,3-d3 and succinic 
acid-13C4 in a volume of 10 μL) was added to each vial, followed by 20 µL of 33% HCl. 
Diethyl ether (1mL) was introduced and the mixture vortexed vigorously for 10 min. 
The two phases were separated by centrifugation (4,000 x g for 5 min at room 
temperature). The upper organic layer was transferred into another clear vial and a 
second diethyl ether extraction was performed. After combining the upper organic layer 
from the two ether extractions, 60 µL of the ether extract and 20 µL of N-tert-
butyldimethylsilyl-N-methyltrifluoroacetamide (MTBSTFA) were mixed in a 100 µL 
glass insert in a GC auto-sampler vial and incubated for 2 h at room temperature. 
Samples were analyzed in a randomized order.  
Derivatized samples (1 µL) were injected with 15:1 split into an Agilent 7890A 
gas chromatography system coupled with 5975C mass spectrometer detector (Agilent, 
CA). Analyses were carried on a HP-5MS capillary column (30 m x 0.25 mm, 0.25 µm 
film thickness, Agilent J & W Scientific, Folsom, CA) using electronic impact (70 eV) as 
ionization mode. Helium was used as a carrier gas at a constant flow rate of 1.26 
mL/min and the solvent delay time was set to 3.5 min. The column head-pressure was 
10 p.s.i. The temperatures of injector, transfer line, and quadrupole were 270°C, 280°C 
and 150°C, respectively. The GC oven was programmed as follows: 45°C hold for 2.25 
min; increase to 200°C at a rate of 20°C/min; increase to 300°C at a rate of 100°C/min; 
hold for 3 min.  
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Quantification of SCFAs was performed by isotope dilution GC–MS using 
selected ion monitoring (SIM). For SIM analysis, the m/z for native and labeled 
molecular peaks for SCFA quantified were: 117 and 122 (acetate), 131 and 136 
(propionate), 145 and 149 (butyrate), 261 and 264 (lactate) and 289 and 293 (succinate), 
respectively. Various concentrations of standards were spiked into control samples to 
prepare calibration curves for quantification. 
Non-targeted GC-MS - Fecal pellets were weighed and 20 volumes of HPLC grade 
water were added. Homogenization was performed using a bead beater without beads 
(mini-beadbeater-8; BioSpec Products; Bartlesville, OK; set on homogenize for 2 min at 
room temperature). After centrifugation (20,000 x g for 10 min at 4°C), a 200 µL aliquot 
of the supernatant was transferred to a clean tube and 400 µL of ice-cold methanol was 
added. The mixture was vortexed vigorously and subsequently centrifuged (20,000 x g 
for 10 min at 4°C). A 500 µL aliquot of the resulting supernatant was combined with 10 
µL of lysine-13C6,15N2 (2 mM) and the mixture dried in a speed vacuum.  
Derivatization of all dried supernatants followed a method adapted with 
modifications from (49). Briefly, 80 µL of methoxylamine solution (15 mg/mL in 
pyridine) was added to methoximate reactive carbonyls and the mixture incubated at 
37ºC for 16 h. This step was followed by replacement of exchangeable protons with 
trimethylsilyl groups using N-methyl-N-(trimethylsilyl) trifluoroacetamide (MSTFA) 
with a 1% v/v catalytic admixture of trimethylchlorosilane (Thermo-Fisher Scientific, 
Rockford, IL) (incubated at 70ºC for 1 h). Heptane (160 µL) was added and an aliquot of 
derivatized samples (1 µL) were injected without split into the Agilent 7890A gas 
chromatography system and coupled 5975C mass spectrometer detector described 
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above. Analyses were carried on a HP-5MS capillary column (see above) with the 
following modifications of the protocol described for targeted GC-MS: helium was used 
at a constant flow rate of 1 mL/min; the solvent delay time was 5.5 min; the column 
head-pressure was 8.23 p.s.i; the temperatures of the injector, transfer line, and source 
were 250°C, 290°C and 230°C, respectively; and the GC oven was programmed for a 
60 °C hold for 2 min, followed by increases to (i) 140°C at 10°C/min, (ii) 240°C at 
4°C/min, and (iii) 300°C at 10°C/min and finally 300°C for 8 min. Metabolites were 
identified by co-characterization of standards. 
Analysis of GC-MS datasets - Data in instrument-specific format (.D) were 
converted to common data format (.cdf) files using MSD ChemStation (E02.01, Agilent, 
CA). CDF files were extracted using the Bioinformatics Toolbox in the MATLAB 7.1 (The 
MathWorks, Inc., Natick, MA), along with custom scripts for alignment of the data in the 
time domain, and automatic integration and extraction of peak intensities. The resulting  
dataset included sample information, peak retention time and peak intensities. Data 
were subsequently mean centered and unit variance was scaled for multivariate analysis. 
Quality control of GC-MS data – As noted above, samples were analyzed in a 
randomized order and metabolite identification was done by co-characterization of 
standards. Pooled quality control (QC) samples were prepared from 20 μL of each 
sample and analyzed together with the other samples. The QC samples were also 
inserted and analyzed every 10 samples. To exclude false positives, raw data for 
statistically significant metabolites were re-evaluated in MSD ChemStation (E02.01, 
Agilent, CA).  
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1H-NMR spectroscopic analyses of urine and plasma - Urinary and plasma samples 
were analyzed using a Bruker 600 MHz spectrometer (Bruker; Rheinstetten, Germany) 
and a standard set of protocols (38). A total of 25 μL of each sample was well mixed with 
30 μL of 0.2 M sodium phosphate buffer [20% deuterium oxide, 0.01% 3-(trimethylsilyl)-
[2,2,3,3-2H4]-propionic acid sodium salt (TSP) and 3 mM sodium azide]. 50 μL of the 
resulting mixture was transferred into a micro-NMR tube with an outer diameter of 1.7 
mm. A standard one-dimensional solvent suppression NMR pulse sequence (recycle 
delay [RD]-90o-t1-90o-tm-90o-acquisition) was used to acquire 1-dimensional (1-D) 1H 
NMR spectral data for both urine and plasma. Additionally, a Carr-Purcell-Meiboom-
Gill (CPMG) pulse sequence [RD-90°-(t-180°-t)n-acquisition] was applied to plasma 
samples to allow visualization of small molecular components without substantial 
interference of macromolecular signals. A total of 512 scans were collected into 64k data 
points (1k equals 1024 data points) with a spectral width of 20 ppm.  
Multivariate data analysis of 1H-NMR spectral data - 1H NMR spectra obtained from 
urine and plasma were automatically phased, referenced and baseline-corrected. The 
resulting NMR spectra (δ0-10) were imported to MATLAB software and digitized into 
20,000 data points with resolution of 0.0005 ppm. The water peak region in urinary 
spectra (δ 4.7-5.05) and plasma CPMG spectra (δ 4.43-5.15) were removed in order to 
minimize the effect of the disordered baseline. The urea peak (δ 5.58-6.17) in urinary 
spectra was also removed, followed by peak alignment (50) and normalization to total 
remaining NMR spectral areas in order to perform further analyses, including principal 
component analysis (PCA) with a log 2 transformed dataset, orthogonal signal 
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correction-projection to latent structures-discriminant analysis (O-PLS-DA) using unit 
variance scaling method, and correlation analysis (SIMCA v13.0 and MATLAB software). 
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Supplementary Figures 
Fig. S1.  PCoA of Hellinger distances generated from microbiome KEGG EC profiles 
of Malawian twin pairs who remained concordant for healthy status and twin pairs 
who became discordant for kwashiorkor. (A) Taken from Fig. 1A showing PC1 
coordinates of all 308 sequenced co-twin fecal microbiomes plotted against age. Each 
sphere represents a microbiome colored by the age of the human donor. (B) Same as 
panel A but colored by the health status of a twin pair (green, concordant for healthy; 
red, discordant for kwashiorkor). (C) PC1 coordinates of fecal microbiomes from twin 
pairs discordant for kwashiorkor (n=215 microbiomes) plotted against age, colored by 
the health status of each co-twin (those who developed kwashiorkor over the course of 
the study are colored in red before and after onset of the disease; healthy co-twin 
samples are colored black). 
Fig. S2.  Hellinger distances within and between the fecal microbiomes of Malawian 
twin pairs who remained healthy, and twin pairs who became discordant for 
kwashiorkor. Hellinger distances were derived from the KEGG EC profiles of healthy 
twin pairs (black bars) and twin pairs discordant for kwashiorkor (red bars). Distances 
between all microbiomes that originate from a given child, and distances between 
microbiomes sampled from a given twin pair, are plotted next to the average distance 
between microbiomes from unrelated children. p<0.0001, unpaired Student’s t-test with 
Bonferroni correction. 
Fig. S3. Relative abundance of Actinobacteria in the fecal microbiomes of healthy 
twin pairs and twin pairs discordant for kwashiorkor.  Percent relative abundance of 
Actinobacteria in the fecal microbiome decreases significantly with 2 weeks of RUTF 
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treatment in co-twins with kwashiorkor but not in their healthy co-twins; *p<0.05 
Friedman test with Dunn’s post hoc test. Data were generated by blasting shotgun reads 
against a database of 462 sequenced human gut microbial genomes.  
Fig. S4. Anthropometric measurements, health status, and functional composition of 
the fecal microbiomes of twin pairs from families 196, 57, and 56. Anthropometric Z 
scores, episodes of diarrhea, fever, cough and vomiting, relative abundance of major 
bacteria taxa based on the BLAST analysis to 462 bacterial genomes for twin pair 196 (A-
C), twin pair 57 (D-F), and twin pair 56 (G-I). The DZ male co-twins from family 196 
were enrolled from the village of Chamba at 2.7-months of age when both were healthy. 
Their last visit took place when they were 34.7-months old. There were no symptoms of 
cough, fever, diarrhea or vomiting at the time when the co-twin with kwashiorkor first 
presented with his disease. The MZ female co-twins from family 57 were enrolled from 
the village Mbiza at 20.6-months of age when both were healthy. Their last visit took 
place when they were 36.2 months old. At the time of presentation of kwashiorkor, the 
affected female presented with two days of fever preceding the clinic visit. The MZ 
female co-twins from family 56 were enrolled from the village Mbiza at 17.2 months of 
age when both were healthy. Their last visit took place when they were 36.3 months old. 
The number of episodes of fever, cough, diarrhea and vomiting were similar between 
the co-twins and was not higher in the child who developed kwashiorkor, either before 
or at the time of presentation with the disease. 
Fig. S5.  Sampling scheme for gnotobiotic mouse recipients of fecal microbiota 
transplants from discordant twin pair 196. A star designates the time point at which a 
sample was used for the indicated analysis.  
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Fig. S6. Efficient transmission of microbiome functions from human donors to 
recipient gnotobiotic mice. (A) Correlation between the percent relative KEGG EC 
abundance in the input fecal microbiomes of twins belonging to discordant pair 196 and 
those in the output fecal microbiomes of mice three weeks after gavage while animals 
were consuming a Malawian diet (M1 phase; mean values ± SEM shown). (B) R-squared 
values for input fecal microbiomes versus microbiomes of individual recipient mice in 
panel A. (C,D) Comparable data as in panels A and B but in this case from co-twins 
belonging to discordant pair 57. 
Fig. S7. PCR-Luminex assays of enteropathogens in human fecal microbota donor 
samples from families 196 and 57, and in mouse experiments involving  fecal 
microbiota transplants from discordant twins in family 196. (A) Fecal samples 
collected from family 196 and family 57 donors, at the time that the co-twin was 
diagnosed with kwashiorkor. (B) Assays of atypical enteropathogenic E. coli (eae) and 
enterotoxigenic E. coli (STh and LT) in input human donor fecal samples and fecal 
samples collected from gnotobiotic mice at the indicated time points on the indicated 
diets. (C) Assay of Cryptosporidium in the same samples used in panel B. Cryptosporidium 
DNA appeared in one gnotobiotic mouse recipient of the kwashiorkor co-twin’s 
microbiota 19 days after gavage and became undetectable shortly after treatment with 
RUTF was initiated.  The degree of weight loss in this animal on the Malawian diet was 
not greater than other members of this treatment group.  Corrected median fluorescence 
intensity (cMFI), a measure of amplicon quantity, is shown on the y-axes. 
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Fig. S8. Weighted UniFrac-based PCoA plots of changes in the phylogenetic 
configurations of the fecal microbiota of gnotobiotic mice containing transplanted gut 
microbial communities from discordant pairs 196 (A, B) and 57 (C, D). Spheres 
represent a single mouse fecal community, and are colored by donor microbiota and 
diet: healthy microbiota recipients consuming a Malawian diet (red) or RUTF (blue); 
kwashiorkor microbiota recipients consuming a Malawian diet (orange) or RUTF 
(green).  
Fig. S9. Non-targeted GC-MS analysis of metabolites in fecal samples collected from 
mice with transplanted microbiota from discordant pair 196. (A,B) PCoA plots, based 
on Hellinger distance measurements, showing the effects of diet on the metabolic 
profile. (C) Heatmap showing Z scores of metabolites with statistically significant 
differences in their levels as a function of diet (p<0.05, unpaired t-test). Samples are 
grouped based on unsupervised hierarchical clustering of metabolite profiles. The 
results reveal that within a ‘donor-diet’ cluster, there is distinction between fecal 
samples obtained during the first versus second exposures to the Malawian diet (M1 and 
M2) as well as early versus late during the course of RUTF treatment [day 2 (D02) 
compared to day 10 (D10)]. Color code: blue, fecal microbiota from gnotobiotic 
recipients of the kwashiorkor co-twin’s microbiota; red, recipients of the healthy co-
twin’s microbiota. 
Fig. S10. Fecal metabolites differentially affected by diet changes in mice harboring 
transplanted healthy versus kwashiorkor co-twin fecal microbiota. (A) Essential amino 
acids. (B) Non-essential amino acids. (C) Urea cycle components. The statistical 
significance of differences observed in pairwise comparisons between the healthy and 
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kwashiorkor treatment group on a given day of a given diet was evaluated using a two-
tailed Student’s t-test. Mean values ± SEM are plotted; p<0.05. 
Fig. S11. Changes in fecal short chain fatty acid and mono- and disaccharide levels as 
a function of donor microbiota and diet. (A) SCFA. (B) Mono- and disaccharides. The 
statistical significance in pairwise comparisons between the healthy and kwashiorkor 
treatment group on a given day of a given diet was evaluated using a two-tailed 
Student’s t-test. Mean values ± SEM are plotted; p<0.05. 
Fig. S12. Procrustes analysis showing correlation between the bacterial phylogenetic 
configurations and metabolic profiles of fecal samples from mice containing 
transplanted microbiota from discordant co-twins in family 196. Every sphere 
represents a single mouse fecal community. For a given type of data, fecal microbiota 
were compared using Hellinger distance measurements. The grey end of each line is 
connected to metabolic data, while the red end is connected to the V4-16S rRNA data. 
The M2 value of 0.380 is the fit of the Procrustes transformation over the first three 
dimensions and is statistically significant (p<0.0001, based on 1000 Monte Carlo 
simulations). (A) Spheres colored based on donor: blue, recipients of the kwashiorkor 
co-twin’s microbiota; red, recipients of the healthy co-twin’s microbiota. (B) Spheres are 
colored based on diet: red, first Malawian diet period; orange, RUTF; blue, second 
Malawian diet period. 
Fig. S13. Non-targeted GC-MS analysis of metabolites in fecal samples collected from 
mice with transplanted microbiota from discordant pair 57. Heatmap of Z scores 
showing metabolites with significant differences in their levels as a function of diet 
(p<0.05, unpaired t-test). Samples are grouped based on unsupervised hierarchical 
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clustering. The results reveal that within a ‘donor-diet’ cluster, there is distinction 
between fecal samples obtained during the first and second exposures to the Malawian 
diet (M1 and M2). 
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Supplementary Tables 
Table S1.  Characteristics of twins with acute malnutrition. 
Table S2.  Fecal metagenomic datasets obtained from healthy twin pairs, from twin 
pairs discordant for kwashiorkor and from mice that were the recipients of human fecal 
microbiota transplants. 
Table S3. List of 462 sequenced human gut-derived microbial genomes used for analysis 
of shotgun sequencing datasets. 
Table S4. Results of the linear mixed-effects regression of PC1, derived from  KEGG EC 
profiles of 308 human microbiomes, with age. 
Table S5.  ECs with significant differences in their representation in the fecal 
microbiomes of co-twins in each twin pair discordant for kwashiorkor, before diagnosis 
of kwashiorkor, at time of diagnosis of kwashiorkor, 2 weeks after initiation of RUTF, 
and 1 month after cessation of RUTF. 
Table S6.  Nutrient analysis of the Malawian and RUTF diets used in this study along 
with nutritional requirements for mice and 1-3 year old humans.  
Table S7.  Proportional representation of species-level taxa in human donor microbiota 
and in fecal samples obtained from gnotobiotic mouse recipients over time during each 
diet period. 
Table S8.  Species-level taxa whose proportional representation was significantly 
different between gnotobiotic mouse recipients of a healthy versus kwashiorkor co-twin 
microbiota transplant, as a function of diet. 
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Table S9. Bacterial taxa whose proportional representation changed significantly as a 
function of diet in gnotobiotic mouse recipients of fecal microbiota transplants from both 
families 196 and 57 compared to changes observed in the other 11 discordant twin pairs. 
Table S10.  Changes of metabolites observed in urinary samples obtained from mice 
with transplanted healthy or kwashiorkor co-twin microbiota from families 196 and 57 
at each diet phase (M1, RUTF, M2). 
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Input Sample Sample ID R square Sy.x
k196A.M1.D19.k3.F 0.9195 0.042
k196A.M1.D19.k4.F 0.92 0.04088
k196A.M1.D19.k6.F 0.9351 0.03793
k196A.M1.D19.k7.F 0.923 0.04123
k196A.M1.D19.k8.F 0.9358 0.038
h196B.M1.D19.h10.F 0.9195 0.042
h196B.M1.D19.h2.F 0.92 0.04088
h196B.M1.D19.h3.F 0.9351 0.03793
h196B.M1.D19.h4.F 0.923 0.04123
h196B.M1.D19.h5.F 0.9358 0.038
h196B.M1.D19.h6.F 0.933 0.03751
h196B.M1.D19.h7.F 0.9236 0.03882
h196B.M1.D19.h8.F 0.8933 0.04835
h196B.M1.D19.h9.F 0.9229 0.04068
Correlation of % EC abundance in input donor sample 
microbiome versus microbiome of recipient mice consuming a 
Malawian diet 19 days after gavage
Correlation of % EC abundance in input donor sample 
microbiome versus microbiome of recipient mice consuming a 
Malawian diet 19 days after gavage
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Family 196 -
kwashiorkor
co-twin
Family 196 -
healthy
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kwashiorkor
co-twin
Family 57 -
healthy
co-twin
Input Sample Sample ID R square Sy.x
k57A.M1.D19.k1.F 0.859 0.05032
k57A.M1.D19.k2.F 0.849 0.05225
k57A.M1.D19.k3.F 0.8443 0.05271
k57A.M1.D19.k4.F 0.7992 0.06039
k57A.M1.D19.k5.F 0.8472 0.05276
h57B.M1.D19.h1.F 0.801 0.06463
h57B.M1.D19.h2.F 0.7922 0.0631
h57B.M1.D19.h3.F 0.786 0.06609
h57B.M1.D19.h4.F 0.7838 0.06556
h57B.M1.D19.h5.F 0.8062 0.06141
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